CLENE NANOMEDICINE
Lobbying client. Federal LDA filings.
- Source id
58412- General description
- Biopharmaceutical company focused on neurodegenerative diseases,including ALS
- State
- UT
- Country
- US
- Principal place of business
- US
- Effective date
- 2024-01-01
- Total spend (across 1 ingested filings)
- $0
Filings (1) — $0
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-21 | Q1 | 2026 | CAPITOL HILL CONSULTING GROUP | — |
Connected on the graph
4 typed relationships in the influence graph — 4 inbound, 0 outbound, grouped by type.
lobbied for (4)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Kimberlee Trzeciak | — | lda_lobbyist_client | |
| — | ← | Christopher Davis | — | lda_lobbyist_client | |
| — | ← | Emily Elizabeth Wilkinson-Holland | — | lda_lobbyist_client | |
| — | ← | Brian Sutter | — | lda_lobbyist_client |